Current Funding Opportunities in type 1 Diabetes
TrialNet funding opportunities:
- Invitation to Negotiate: Mechanistic Analysis of Stored Samples from the TrialNet Immune Effects of Oral Insulin Trial
Type 1 Diabetes TrialNet intends to award funding to investigators to analyze biosamples from the "Exploring Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus" Trial (TN20). Investigators should assemble a team that can design and conduct rigorous and validated assays on samples, and analyze the results jointly with the TrialNet Data Coordinating Center (TNCC) using clinical and other data collected from subjects.
Letter of Intent (required) due August 3, 2016
Proposals due September 27, 2016
NIH general announcement for all investigator-initiated research: